Clinical management of beta-thalassemia major (Q34404492)

2 August 2017

1 reference

title

Clinical management of beta-thalassemia major (English)

1 reference

2 August 2017

1 reference

Wonke B

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

published in

Seminars in Hematology

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

350-359

1 reference

The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Cholelithiasis in children with thalassemia major: an ultrasonographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

1 reference

7 January 2021

Effects of calcitonin therapy on osteoporosis in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Genotype-phenotype correlations in beta-thalassemias.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Incidence of AIDS in HIV-1 infected thalassaemia patients. European and Mediterranean W.H.O. Working Group on Haemoglobinopathies and Cooleycare

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

GH Secretion in Thalassemic Patients with Short Stature

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Induction of spermatogenesis in thalassaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Cholelithiasis in Thalassemia Major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Early left ventricular dysfunction and chelation therapy in thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

High prevalence of low bone mass in thalassaemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Lifetime treatment costs of beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Ultrastructural pathology of the heart in patients with beta-thalassaemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Human immunodeficiency virus infection in multi-transfused patients with thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Hypertransfusion regimen in patients with Cooley's anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Bone disease in children with homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Primary hypothyroidism and the low T3 syndrome in thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Histochemical Studies of the Myocardium and Conduction System in Acquired Iron-Storage Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Expanding role of bisphosphonate therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Bone resorption is increased in young adults with thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Leucocyte depletion of the blood supply - how will patients benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Bone disease in beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

Survival and causes of death in thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990029-0

7 January 2021

10.1016/S0037-1963(01)90029-0

Identifiers

DOI

1 reference

2 August 2017

1 reference